Australian Clinical Labs Ltd (AU:ACL) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Australian Clinical Labs Ltd has announced an update on its ongoing share buy-back program, revealing that it repurchased 125,000 shares on the previous day. This move brings the total number of shares bought back to 955,864, highlighting the company’s strategy to potentially enhance shareholder value.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.